Close Menu

NEW YORK (GenomeWeb News) – The US House of Representatives and the Senate have passed the Pandemic All Hazards Preparedness Reauthorization Act of 2013, which will provide several billion dollars for development and stockpiling of medical countermeasures (MCMs) for chemical, biological, radiological, and nuclear (CBRN) attacks.

The bill cleared both the House and Senate with overwhelming support over the past few days and has now been submitted to the White House.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Los Angeles brought and settled a civil enforcement action against the makers of an at-home test for SARS-CoV-2, NPR reports. 

The Guardian reports that Cancer Research UK is cutting its research funding by £44 million.

Technology Review examines factors affecting SARS-CoV-2 testing turnaround times.

In PNAS this week: mapping of ancient human migrations in Europe, recurrent gene fusion in breast cancer, and more.